We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Graphitic Carbon Forms Lubricating Layer on Hip Implants

By HospiMedica International staff writers
Posted on 09 Jan 2012
A new study reveals that graphitic carbon seems to be a key ingredient in the lubricating layer that forms around metal-on-metal implants, an important factor in designing longer lasting devices.

Researchers at Rush University Medical Center (Chicago, IL, USA), the University of Duisburg-Essen (Germany), and Northwestern University (Evanston, IL, USA) studied seven implants that were retrieved from patients for a variety of reasons. More...
The researchers used a number of analytical tools, including electron and optical microscopies, to study the tribological layer that formed on the metal parts. Electron-energy loss spectra--a method of examining how the atoms are bonded--showed a well-known fingerprint of graphitic carbon. This, together with other evidence, led the researchers to conclude that the layer actually consists primarily of graphitic carbon, a well-established solid lubricant, and not proteins secreted by natural joints.

According to the researchers, metal-on-metal implants have added advantages over other types of implants, since they are a lower wear alternative to metal-on-polymer devices and also allow for larger femoral heads, which can reduce the risk of hip dislocation, one of the more common reasons for additional surgery. Metal-on-metal is also is the only current option for a hip resurfacing procedure, a bone-conserving surgical alternative to total hip replacement. Manipulating the implant design to encourage the production of graphitic surfaces could improve and prolong the performance of these implants. The study was published in the December 23, 2011, issue of Science.

“Hip replacement surgery is the greatest advancement in the treatment of end-stage arthritis in the last century,” said study coauthor Professor of orthopedic surgery Joshua Jacobs, MD, chair of the department of orthopedic surgery at Rush. “By the time patients get to me, most of them are disabled; life is unpleasant. They have trouble working, playing with their grandchildren or walking down the street. Our findings will help push the field forward by providing a target to improve the performance of hip replacements. That’s very exciting to me.”

Related Links:
Rush University Medical Center
University of Duisburg-Essen
Northwestern University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.